PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
11-Aug-2021 Precision for Medicine and Trialbee Partner to Advance Clinical Trials for Complex Therapies and Speed Shift Toward Precision Medicine Precision for Medicine
11-Aug-2021 DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients DFE Pharma
11-Aug-2021 Advanced Clinical Continues Global Expansion into Europe with Ireland Office Advanced Clinical
11-Aug-2021 ViewMind announces developer agreement with HP to help revolutionise the diagnosis and treatment of cognitive disorders ViewMind
11-Aug-2021 Medical Clothing Market Size, Industry Share, Trends, Demand, Revenue, Opportunities, Future Plans, Competitive Landscape and COVID-19 Impact Analysis 2028 The Wire Times
11-Aug-2021 $14.4 Bn Fruit & Vegetable Seeds Markets: Solanaceae, Cucurbit, Root & Bulb, Brassica, Leafy, and Other Families - Global Forecast to 2025 - ResearchAndMarkets.com Businesswire
11-Aug-2021 Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone Mission Therapeutics
11-Aug-2021 ASLAN PHARMACEUTICALS REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE ASLAN PHARMACEUTICALS
11-Aug-2021 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market 2021 Growth, Trends, Leading Players, and Business Insights Forecast to 2026 CDN Newswire
11-Aug-2021 NICE RECOMMENDS KITE’S TECARTUS®▼ FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA (MCL) AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY INCLUDING A BRUTON’S TYROSINE KINASE (BTK) INHIBITOR IN ENGLAND WITHIN THE CANCER DRUGS FUND Kite
11-Aug-2021 Melanoma Cancer Diagnostics Market is expected to register CAGR of 4.7% by the end of 2028 MARKITWIRED Latest Market Reports
11-Aug-2021 Polyplus launches FectoVIR(R)-AAV GMP transfection reagent for large scale viral vector production to overcome commercial gene and cell therapy manufacturing barriers Polyplus
11-Aug-2021 Nouscom highlights innovative science behind VENUS, its novel algorithm for identifying and prioritizing patient-specific tumor neoantigens for personalized cancer immunotherapy Nouscom
11-Aug-2021 GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex GW Pharmaceuticals
11-Aug-2021 Santen and Sydnexis execute an exclusive licensing agreement for SYD-101, a novel investigational treatment for progressive childhood myopia Santen and Sydnexis
11-Aug-2021 Subscription to raise £1,000,000 to progress proprietary TYK2/JAK1 programmes into clinical development Sareum Holdings plc
11-Aug-2021 FORXIGA (dapagliflozin) APPROVED IN GREAT BRITAIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AstraZeneca
11-Aug-2021 Spectral MD hosts event to launch a multi-center clinical study for burn wounds Spectral MD Holdings, Ltd
11-Aug-2021 Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes AstraZeneca
11-Aug-2021 Just - Evotec Biologics opens J.POD® 1 US in Redmond, Washington Evotec